Effects of Maraviroc vs. Efavirenz on CD4/CD8 Ratio

NCT03178084 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

721

Enrollment

OTHER

Sponsor class

Conditions

HIV/AIDS

Interventions

DRUG: Maraviroc (UK-427,857) QD + Zidovudine/Lamivudine BID
DRUG: Efavirenz QD + Zidovudine/Lamivudine BID
DRUG: Maraviroc (UK-427,857) BID + Zidovudine/Lamivudine QD

Sponsor

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal